Silco Pharmaceuticals Limited (DSE:SILCOPHL)

Silco Pharmaceuticals Statistics

Total Valuation

DSE:SILCOPHL has a market cap or net worth of BDT 1.47 billion. The enterprise value is 1.45 billion.

Market Cap	1.47B
Enterprise Value	1.45B

Important Dates

The last earnings date was Thursday, January 29, 2026.

Earnings Date	Jan 29, 2026
Ex-Dividend Date	Dec 17, 2025

Share Statistics

DSE:SILCOPHL has 103.81 million shares outstanding. The number of shares has decreased by -2.36% in one year.

Current Share Class	103.81M
Shares Outstanding	103.81M
Shares Change (YoY)	-2.36%
Shares Change (QoQ)	-1.97%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	0.61
P/TBV Ratio	0.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.73, with a Debt / Equity ratio of 0.00.

Current Ratio	4.73
Quick Ratio	2.10
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	1.98%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	5.43%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	313
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.13% in the last 52 weeks. The beta is 0.22, so DSE:SILCOPHL's price volatility has been lower than the market average.

Beta (5Y)	0.22
52-Week Price Change	-10.13%
50-Day Moving Average	13.79
200-Day Moving Average	14.59
Relative Strength Index (RSI)	55.00
Average Volume (20 Days)	376,248

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	n/a
Pretax Income	n/a
Net Income	n/a
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 31.90 million in cash and 3.78 million in debt, with a net cash position of 28.12 million or 0.27 per share.

Cash & Cash Equivalents	31.90M
Total Debt	3.78M
Net Cash	28.12M
Net Cash Per Share	0.27
Equity (Book Value)	2.41B
Book Value Per Share	23.57
Working Capital	818.66M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.11, which amounts to a dividend yield of 0.77%.

Dividend Per Share	0.11
Dividend Yield	0.77%
Dividend Growth (YoY)	10.00%
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	2.36%
Shareholder Yield	3.13%
Earnings Yield	n/a
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 20, 2019. It was a forward split with a ratio of 1.1.

Last Split Date	Nov 20, 2019
Split Type	Forward
Split Ratio	1.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1